Citation Impact
Citing Papers
A Sulfilimine Bond Identified in Collagen IV
2009 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
2012
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
A Role for Collagen IV Cross-links in Conferring Immune Privilege to the Goodpasture Autoantigen
2008
Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
2006 StandoutNobel
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
1997
Contribution of Angiotensin II to Late Renal Injury after Acute Ischemia
2000
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms
2005 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells
2005
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins
1995
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Chronic kidney disease: the global challenge
2005
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Mesenchymal stem cells in health and disease
2008 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Organoid Models and Applications in Biomedical Research
2015 Standout
Renal handling of albumin: A critical review of basic concepts and perspective
2002
Uric Acid and Cardiovascular Risk
2008 Standout
Sirtuins, Aging, and Medicine
2011
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
2013
G Protein-coupled Receptors Mediate Two Functionally Distinct Pathways of Tyrosine Phosphorylation in Rat 1a Fibroblasts
1997 StandoutNobel
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
P1 blood group antigen expression and epidemic hemolytic uremic syndrome
1995
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Evaluation of the Role of Shiga and Shiga-like Toxins in Mediating Direct Damage to Human Vascular Endothelial Cells
1991
A Molecular Signature of Proteinuria in Glomerulonephritis
2010
Intrarenal cells, not bone marrow–derived cells, are the major source for regeneration in postischemic kidney
2005
Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
2013 Standout
Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus
2006
Endothelin antagonists
1999
Role of verotoxin receptors in pathogenesis
1996
Systemic Lupus Erythematosus
2011 Standout
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
1999
Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system
1996
Recent progress in the biology and physiology of sirtuins
2009 Nature
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Nuclear Signaling by Endothelin-1 Requires Src Protein-tyrosine Kinases
1996
Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats
2005
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
TGFβ in Cancer
2008 Standout
Regulatory peptides and their antagonists in nephropathies
2000
Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
1998
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
The Genetics of Aging: A Vertebrate Perspective
2019
The Role of Lipopolysaccharide and Shiga-like Toxin in a Mouse Model of Escherichia coli O157:H7 Infection
1997
Cellular Response to Injury in Membranous Nephropathy
2005
Potential approaches to reverse or repair renal fibrosis
2014
Cerebral organoids model human brain development and microcephaly
2013 StandoutNature
Sequential Therapies for Proliferative Lupus Nephritis
2004
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys
2005
Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kB activation
1998
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor
1997 StandoutNobel
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Role of tissue stroma in cancer cell invasion
2003
Modeling Development and Disease with Organoids
2016 Standout
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
2001
Effects of an Endothelin Receptor Antagonist in Rats With Cyclosporine-Induced Hypertension
1995
Role for Thromboxane Receptors in Angiotensin-II–Induced Hypertension
2004
Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease
2005
Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2
1996
Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits
1997
Molecular insights into renal interstitial fibrosis.
1996
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1
2000
Angiotensin-Converting Enzyme II in the Heart and the Kidney
2006
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
1992 StandoutScience
Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions
1995
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice
1994
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
2007
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views
2007 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Vasoactive hormones and renal sclerosis
1996
Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer.
2015
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
1995 StandoutNobel
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.
1991 StandoutNobel
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
1993
A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.
1993 StandoutNobel
Voltage-Insensitive Ca2+Channels and Ca2+/Calmodulin-Dependent Protein Kinases Propagate Signals from Endothelin-1 Receptors to the c-fosPromoter
1996
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
2005
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages
1994
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
1998 Standout
Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues
1994
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
1996 StandoutNobel
Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.
1991
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
1998
Works of Daniela Corna being referenced
Time course and localization of endothelin-1 gene expression in a model of renal disease progression.
1997
Angiotensin II Blockade Limits Tubular Protein Overreabsorption and the Consequent Upregulation of Endothelin 1 Gene in Experimental Membranous Nephropathy
1998
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis
2003
Proximal tubular cells promote fibrogenesis by TGF-β1–mediated induction of peritubular myofibroblasts
2002
Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney
1996
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist
1997
Angiotensin-Converting Enzyme nhibition Prevents Glomerular-Tubule Disconnection and Atrophy in Passive Heymann Nephritis, an Effect Not Observed with a Calcium Antagonist
2001
Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen
1998
Effect of combining ACE inhibitor and statin in severe experimental nephropathy
2002
Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat
2003
In Vivo Maturation of Functional Renal Organoids Formed from Embryonic Cell Suspensions
2012
V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin–angiotensin system inhibition in rats with renal mass reduction
2009
Role of endothelium-derived nitric oxide in the bleeding tendency of uremia.
1990
Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy
1998
How To Fully Protect the Kidney in a Severe Model of Progressive Nephropathy
2002
Insulin-Like Growth Factor-1 Sustains Stem Cell–Mediated Renal Repair
2007
Renal protective effect of angiotensin-converting enzyme inhibition in aging rats
1992
Protein traffic activates NF-kB gene signaling and promotes MCP-1–dependent interstitial inflammation
2000
Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression
1993
Mesenchymal Stem Cells Are Renotropic, Helping to Repair the Kidney and Improve Function in Acute Renal Failure
2004
Disruption of the Ang II type 1 receptor promotes longevity in mice
2009
Sequence of Glomerular Changes in Experimental Endotoxemia: A Possible Model of Hemolytic Uremic Syndrome
1989
Combining an Antiproteinuric Approach with Mycophenolate Mofetil Fully Suppresses Progressive Nephropathy of Experimental Animals
1999
Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
1999
Proteasomal Processing of Albumin by Renal Dendritic Cells Generates Antigenic Peptides
2008
In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation.
1998
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression
1993
Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.
1992
Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
1997
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects
2012
Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.
1990
Tumor necrosis factor induces glomerular damage in the rabbit.
1989
Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
1997